7th NovAliX Conference

Biophysics in Drug Discovery 2019 | Asian Edition

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

 Kyoto, Japan    November 13-15, 2019

Keynote Speakers

Structure-biophysics Driven PROTAC Design for Degrading Undruggable Cancer Targets (KL01)

Prof. Alessio CIULLI
Prof. Alessio CIULLI
UNIVERSITY OF DUNDEE, Dundee, United Kingdom
Read more

From Fragments to Pharmaceuticals (KL02)

Dr Harren JHOTI
Dr Harren JHOTI
ASTEX PHARMACEUTICALS, Cambridge, United Kingdom
Read more

Session 1: Recent Advances in FBDD

Enabling Drug Discovery with Crude Reaction Mixture Screening (IL03)

Dr Ben DAVIS
Dr Ben DAVIS
VERNALIS RESEARCH, Cambridge, United Kingdom
Read more

PhABits – Shining New Light on Fragments Approaches for Assessing Targets Tractability (IL01)

Dr Mike HANN
Dr Mike HANN
GSK MEDICINES RESEARCH CENTRE, Stevenage, United Kingdom
Read more

Ligand-Based Fluorine NMR Screening in Drug Discovery (IL02)

Dr Anna VULPETTI
Dr Anna VULPETTI
NOVARTIS, Basel, Switzerland
Read more

Session 2: Challenging Targets (GPCRs, Ion Channels...)

Advancing Cryo-EM for Determination of G Protein-Coupled Receptor Structure (IL05)

Prof. Patrick M. SEXTON
Prof. Patrick M. SEXTON
MONASH UNIVERSITY, Parkville, Australia
Read more

Structural Biology of Seven-Transmembrane Receptors Toward Drug Discovery (IL04)

Prof. Shigeyuki YOKOYAMA
Prof. Shigeyuki YOKOYAMA
RIKEN, Yokohama City, Japan
Read more

Session 3: Cryo-EM in Drug Discovery

Advancing Drug Discovery in Pharma Using Cryo-EM (IL06)

Dr Claudio CIFERRI
Dr Claudio CIFERRI
GENENTECH, South San Francisco, United States
Read more

Session 4: X-ray Crystallography / Cryo-EM Complementarity

Increased Performance in High-Throughput Compound and Fragment Screening Campaigns by the Use of "Club Class" Data Collection (IL07)

Dr Gerard BRICOGNE
Dr Gerard BRICOGNE
GLOBAL PHASING LTD., Cambridge, United Kingdom
Read more

Applying Hybrid Biophysical and Structural Methods to Study Allosteric Regulation of GTP Cyclohydrolase I - A Target for Treating Inflammatory and Neuropathic Pain (IL09)

Dr Herbert NAR
Dr Herbert NAR
BOEHRINGER INGELHEIM, Biberach, Germany
Read more

Discovery of a Regulatory Subunit of the Yeast Fatty Acid Synthase (IL08)

Prof. Holger STARK
Prof. Holger STARK
MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY, Göttingen, Germany
Read more

Session 5: Hot Topics

Re-energizing Small Molecule Drug Discovery by Centaur Chemist™ (IL10)

Dr Daisuke TANAKA
Dr Daisuke TANAKA
EXSCIENTIA, Osaka, Japan